Bioactive Microfibre Gelling™ (BMG™) Technology: In Vitro Testing of this New Innovative Dressing

Bioactive Microfibre Gelling™ (BMG) Technology – In Vitro Testing of This New Innovative Dressing with Inherent Bioactive and Antimicrobial Properties

The dressing exhibited excellent antimicrobial activity, reducing the risk of infections.
Excellent anti microbial activity was demonstrated with a >4 log reduction of bacterial numbers of major wound pathogens including drug-resistant strains within 24hrs.
Shrinkage of the dressing was minimal and wet tensile strength was >3 Newtons; 3 times stronger than competitor dressing..
The volume of fluid absorbed in a 10x10cm dressing was 80-85ml; twice the volume of a leading competitor

The combination of chitosan’s inherent antimicrobial properties and innovative microfibre structure makes this dressing highly effective for wound care.
The study confirms that MaxioCel, utilizing BMG technology, provides superior exudate management, infection control, and bioactive wound healing properties, making it a valuable advanced wound care solution.
The findings suggest that this dressing could significantly improve healing outcomes in chronic and complex wounds.

Evaluation of a 100% Chitosan Dressing in the Treatment of Diabetic Foot Ulcers

Chronic Wound Debridement in an Acute Setting

Severe Pressure Ulcer Debridement in the Acute Sector

A Multi-disciplinary Team Approach to the Management